Mussallem CHD Alliance

What Mussallem CHD Alliance does

Mussallem CHD Alliance (MCA) is a nonprofit advocacy and grant-making organization established in 2025 as the flagship initiative of the Linda and Mike Mussallem Foundation and publicly launched in January 2026. The Alliance is dedicated to improving survival and quality of life for people born with congenital heart defects (CHD), a condition affecting approximately 1 in 100 babies worldwide. It serves CHD patients and families, clinicians and researchers, early-career interventional cardiologists, academic medical centers, and therapeutic researchers by funding programs across the innovation-to-patient pathway.

The Alliance operates a portfolio of eight named programs rather than a single technology product. These include the PICS Society Mussallem Early Career Development Academy (global mentorship for early-career CHD interventional cardiologists), the Stanford Mussallem Center for Biodesign Innovation Fellowship (a 10-month paid fellowship), the Columbia University Translational Research Collaboration (SAVE device and biomaterials for pediatric heart valve durability), AATS Travel Grants (supporting 70+ congenital surgeons to attend the AATS Annual Meeting), the Mussallem Family Camp with Camp del Corazon (family support retreat), the Boston Children's Hospital Positive Fitness Hub (exercise cardiology initiative), the Blue Sky Therapeutics RFP (novel therapeutic research funding), and the Every 100th Heart National CHD Advocacy Summit (federal policy advocacy). The Alliance also participated as an investor in BrightHeart's €11M Series A round, marking its first direct venture investment in AI-enabled prenatal CHD detection.

The organization is founder-led by Linda Mussallem and Mike Mussallem (former Chairman and CEO of Edwards Lifesciences), with an executive team led by President Orin Herskowitz (former Columbia University SVP of Applied Innovation). Headcount is reported at 1-10 employees, consistent with a lean nonprofit operating model. The Alliance does not sell products or services; its work is delivered through strategic philanthropy, grant-making, and partnerships with academic, clinical, and advocacy institutions, financed by the parent foundation.

Name

Mussallem CHD Alliance

Legal name

Mussallem CHD Alliance

Website

https://mussallemchdalliance.org

Company type

Private

Founded year

2025

Operating status

Operating

Headcount range

1–10 employees

Short description

Mussallem CHD Alliance is a nonprofit grant-making organization, launched in 2026 as the flagship initiative of the Linda and Mike Mussallem Foundation, dedicated to accelerating innovation and care for people born with congenital heart defects (CHD) through partnerships with academic, clinical, and advocacy institutions.

Ownership category

akta.pro rank

Product category

Healthcare Advocacy and Research Philanthropy

NAICS

Voluntary Health Organizations (813212), Other Individual and Family Services (624190)

SIC

Services-Social Services (8300), Services-Misc Health & Allied Services, Nec (8090)

akta.pro primary industry

Rare Disease & Special Needs Support Organizations (BPAGACAM)

akta.pro secondary industries

Global Health Research, Evidence & Technical Assistance Organizations (HLAJAKAN), Global Health Research, Clinical Trials & Product Development Partnerships (PDPs) (HLAJAOAM)

Keywords

• Congenital heart disease
• Heart defect research
• Nonprofit health alliance
• Medical research grants
• Cardiology advocacy

GTM type

B2B

Offering type

Services

Cost components

Grants and program funding distributed to partner institutions and researchers, Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Distribution channels1 record

Marketing channels7 records

Core offering

Mussallem CHD Alliance is a nonprofit healthcare alliance that funds and convenes research, education, and clinical innovation programs for people born with congenital heart defects. It delivers impact through grant programs, paid fellowships, translational research collaborations, family support retreats, advocacy summits, and investments in companies developing CHD-relevant technologies. Its programs are executed in partnership with academic institutions (Columbia University, Stanford Biodesign), clinical organizations (PICS Society, AATS, Boston Children's Hospital), and community nonprofits (Camp del Corazon, Every 100th Heart).

Product overview

The Mussallem CHD Alliance is a nonprofit healthcare alliance (not a technology product company) focused on transforming care for people born with congenital heart defects through strategic philanthropy, research funding, education, and clinical innovation. The organization does not offer a traditional technology product or software platform. Instead, it operates a portfolio of grant programs, fellowships, and collaborative initiatives including: the PICS Society Mussallem Early Career Development Academy (global mentorship for CHD interventional cardiologists); the Mussallem CHD Alliance Innovation Fellowship (in partnership with Stanford Mussallem Center for Biodesign); the Columbia University Translational Research Collaboration (heart valve durability research); AATS Travel Grants (surgeon training access); the Mussallem Family Camp (family support program with Camp del Corazon); the Boston Children's Hospital Positive Fitness Hub (exercise and wellness initiative); the Blue Sky Therapeutics RFP (novel therapeutic research funding); and the Every 100th Heart advocacy initiative. These programs work together to improve patient access to care, boost quality of life, and propel transformational technologies for CHD patients from first heartbeat onward.

Differentiator

Problem solved

Functional benefit

Products and services

• PICS Society Mussallem Early Career Development Academy A two-year global mentorship program for early-career congenital heart disease interventional cardiologists within five years of completing training. The Academy blends mentorship, team-based research, leadership opportunities, and engagement with senior interventional cardiologists and industry R&D innovators.
• Mussallem CHD Alliance Innovation Fellowship A full-time, 10-month paid academic fellowship supported by Stanford Mussallem Center for Biodesign and Impact. The fellowship empowers fellows to apply the Stanford Biodesign process to tackle pressing challenges in CHD care through clinical immersion and needs research. The program builds upon Dr. Ignacio Pérez's identification of over 200 unmet needs in the CHD landscape.
• Columbia University Translational Research Collaboration Two complementary research programs at Columbia University Vagelos College of Physicians and Surgeons led by Dr. Giovanni Ferrari addressing heart valve durability: the SAVE (Scaffold-Assisted Valve Evaluation) device for preserving and testing living donor heart valves, and engineering next-generation biomaterials for reconstructive heart surgery.
• Mussallem CHD Alliance Travel Grant (AATS) A grant enabling more than 70 aspiring congenital heart surgeons from around the world to attend the AATS 106th Annual Meeting and Congenital Valve Symposium, with reserved funding for early-career surgeons from low-to-middle income countries.
• Mussallem Family Camp A two-year pilot three-day weekend retreat program designed for entire CHD families, offering educational workshops and activities segmented for parents, siblings, and CHD patients. Developed in partnership with Camp del Corazon, a 501(c)(3) nonprofit founded in 1995. After the pilot, the program will be codified into a shareable playbook and toolkit to be made available to more than 30 CHD camps across the country.
• Boston Children's Hospital Positive Fitness Hub A two-part initiative led by Dr. Naomi Gauthier and Dr. Tracy Curran to advance structured exercise and positive psychology in CHD care. It includes a national discovery effort for digital innovation opportunities in exercise cardiology, and a web-based Positive Fitness Hub providing educational modules, clinician tools, and an interactive community space for providers.
• Blue Sky Therapeutics RFP The organization's first research request for proposals focused on novel therapeutic approaches for congenital heart defects. It supports early-stage research in gene therapies, RNA medicines, cell therapies, biologic drugs, and precision drug delivery — areas where most medicines today are prescribed off-label for CHD patients.
• Every 100th Heart National CHD Advocacy Summit A national advocacy initiative and annual summit bringing together patients, families, clinicians, researchers, and advocates to elevate congenital heart defects as a federal health policy priority. MCA serves as a founding partner; the inaugural summit on May 19-20, 2026 connected with over 200 members of the CHD community.

Quantifiable outcome

• Launched first Research RFP focused on Blue Sky Therapeutics for CHD to fund early-stage research
• +2 more outcomes

Segments5 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Seven partnerships are on record, tiered core and flagship.

• Every 100th HeartcoreStrategic or Co-development PartnerEvery 100th Heart is a founding partner with MCA. On May 19-20, 2026, Every 100th Heart hosted its first annual National CHD Advocacy Summit, bringing together patients, families, clinicians, researchers, and advocates to elevate CHD as a national health policy priority. The event connected with over 200 members of the CHD community.
• Camp del CorazonflagshipStrategic or Co-development PartnerMCA and Camp del Corazon launched the Mussallem Family Camp, a two-year pilot program designed to support, educate, and bring together entire families of children living with CHD. The three-day weekend retreat offers tailored programming for parents, siblings, and CHD patients. Camp del Corazon is a 501(c)(3) nonprofit founded in 1995 providing free, year-round experiential programming for children and families living with heart disease.
• Columbia UniversityflagshipStrategic or Co-development PartnerMCA announced translational research collaboration with Columbia University Vagelos College of Physicians and Surgeons led by Dr. Giovanni Ferrari. The partnership supports two research programs addressing heart valve durability: the SAVE (Scaffold-Assisted Valve Evaluation) device for preserving and testing living donor heart valves, and engineering next-generation biomaterials for reconstructive heart surgery.
• PICS Society (Pediatric and Congenital Interventional Cardiovascular Society)coreStrategic or Co-development PartnerMCA awarded a multi-year grant to support the PICS Society Early Career Development Academy, renamed the PICS Society Mussallem Early Career Development Academy. The two-year global program mentors early-career CHD interventional cardiologists during their first years in practice, providing mentorship, team-based research, leadership opportunities, and engagement with senior interventional cardiologists and industry R&D innovators.
• Boston Children's HospitalcoreStrategic or Co-development PartnerMCA supports a new initiative at Boston Children's Hospital led by Dr. Naomi Gauthier and Dr. Tracy Curran to advance structured exercise and positive psychology in CHD care. The two-part initiative includes a national discovery effort for digital innovation opportunities and development of a Positive Fitness Hub website with scalable resources and clinician education.
• Stanford Mussallem Center for Biodesign and ImpactcoreStrategic or Co-development PartnerMCA supports the Stanford Mussallem Center for Biodesign and Impact through the Mussallem CHD Alliance Innovation Fellowship. This full-time, 10-month paid academic opportunity empowers fellows to apply the Stanford Biodesign process to tackle pressing challenges in CHD care. The fellowship builds upon Dr. Ignacio Pérez's work identifying over 200 unmet needs in the CHD landscape.
• AATS Foundation (American Association for Thoracic Surgery)coreStrategic or Co-development PartnerMCA provided a grant to the AATS Foundation for the Mussallem CHD Alliance Travel Grant, enabling more than 70 aspiring congenital heart surgeons from around the world to attend the AATS 106th Annual Meeting and AATS Congenital Valve Symposium in Chicago (May 1-5, 2026). A portion is reserved for early-career surgeons from low-to-middle income countries.

Scale indicators3 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Adult Congenital Heart Association (ACHA): National nonprofit dedicated to improving and extending the lives of those born with congenital heart defects through education, advocacy, and research funding. Serves as the closest direct peer to MCA's patient-advocacy and CHD-research mission, though MCA's scope is broader and more innovation-focused.
• Children's Heart Foundation: The leading nonprofit focused exclusively on funding congenital heart defect research. Comparable to MCA's research grantmaking arm (Columbia, Blue Sky Therapeutics RFP), though MCA pairs research funding with a broader innovation-to-patient pathway including training, advocacy, and investment.
• Camp del Corazon: 501(c)(3) nonprofit founded in 1995 providing free, year-round experiential programming for children and families living with heart disease. Direct partner of MCA via the Mussallem Family Camp and the most operationally comparable peer in the family-support and CHD-camp space.
• Mended Little Hearts: National nonprofit providing support to children with congenital heart defects and their families. Comparable to MCA's Mussallem Family Camp and family support mission, though MCA pairs family support with substantial research and innovation funding.
• Conquering CHD: CHD-focused nonprofit advocating for patient care, research funding, and federal policy. Closely aligned with MCA's Every 100th Heart advocacy initiative and overall awareness-elevation thesis, but smaller and more grassroots.

Broad incumbents

• American Heart Association: The largest U.S. cardiovascular nonprofit with massive research funding, advocacy, and public health programs. Operates broadly across cardiovascular disease with CHD as a subset; competes with MCA for donor mindshare and federal policy attention.
• Children's Hospital Association: National association representing children's hospitals, including major CHD treatment centers like Boston Children's. Comparable as an institutional convening body spanning advocacy, research, and clinical care, though operating at a much larger scale and representing provider organizations rather than patients.

Emerging players

• Kids With Heart National Association for Children's Heart Disorders: Nonprofit dedicated to providing support, education, and awareness for families affected by congenital heart defects. Comparable to MCA's patient-and-family support mission with a similar grassroots approach.
• Brave Hearts Strong Starts: Emerging CHD-focused nonprofit supporting pediatric heart patients and their families through programming and advocacy. A smaller-scale peer in the same patient-and-family support space where MCA operates.
• Heart to Heart: CHD-focused nonprofit combining family support, awareness, and research advocacy. Smaller and more programmatic than MCA but addresses the same patient population with overlapping peer-support and outreach missions.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/@MussallemCHDAlliance
• LinkedInlinkedin.com/company/mussallemchdalliance
• Instagraminstagram.com/mussallemchdalliance/?igsh=NTc4MTIwNjQ2YQ%3D%3D&utm_source=qr

Revenue estimate

Valuation estimate

Number of profiles

Profiles11 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Mussallem CHD Alliance